BUKWANG PHARMACEUTICAL IND CO.,LTD

R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.

003000 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 동작구 대방동1길 47, 서울특별시
Website:: https://www.bukwang.co.kr/en/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bukwang Pharmaceutical Co., Ltd. is an R&D-focused pharmaceutical company engaged in the development, manufacturing, and commercialization of therapeutic drugs. The company employs an 'open innovation' strategy, utilizing strategic investments, joint ventures, research collaborations, and acquisitions to expand its drug pipeline and enhance its global competitiveness. Its development pipeline targets a range of conditions, with a focus on central nervous system (CNS) disorders such as schizophrenia (Lurasidone) and Parkinson's disease (JM-010), as well as oncology (SOL-804 for prostate cancer), liver diseases, and metabolic disorders. Through continuous research and strategic partnerships, Bukwang aims to become a global pharmaceutical innovator.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BUKWANG PHARMACEUTICAL IND CO.,LTD and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size
2025-08-29 00:00	Related Party Transaction 대규모기업집단현황공시[분기별공시(개별회사용)]	Korean	10.5 KB
2025-08-14 00:00	Interim Report 반기보고서 (2025.06)	Korean	1.6 MB
2025-08-14 00:00	Regulatory News Service 지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항	Korean	11.3 KB

Automate Your Workflow. Get a real-time feed of all BUKWANG PHARMACEUTICAL IND CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BUKWANG PHARMACEUTICAL IND CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
SEYİTLER KİMYA SANAYİ A.Ş. Manufacturer of medical tapes, wound dressings, and first aid plasters for the healthcare industry.	Türkiye	SEYKM
Shaperon Inc. Develops inflammasome inhibitors & nanobodies for inflammatory diseases and cancer.	South Korea	378800
Shedir Pharma Group Develops and sells pharmaceutical, nutraceutical, and dermo-cosmetic products in Italy & Spain.	Italy	SHE
SHIELD THERAPEUTICS PLC Commercializing a novel oral therapy for adults with iron deficiency.	United Kingdom	STX
SHINPOONG PHARMACEUTICAL CO.,LTD R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.	South Korea	019170
Shionogi & Co.,Ltd. A research-driven pharmaceutical firm creating drugs, diagnostics, and devices for global health.	Japan	4507
Siegfried Holding AG Global CDMO providing development and manufacturing of APIs and finished drugs for the pharma industry.	Switzerland	SFZN
SillaJen, Inc. Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.	South Korea	215600
SK biopharmaceuticals Co., Ltd. Develops and commercializes CNS and oncology therapies for global markets, focusing on the U.S.	South Korea	326030
SK Bioscience Co.,Ltd A global biotech firm developing vaccines for diseases like COVID-19, influenza, and shingles.	South Korea	302440